Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 168
Selected: 0
NCT IDTitle
NCT04287478Bacteriophage Therapy in Patients With Urinary Tract Infections
NCT07923526An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
NCT04084678Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects
NCT00262106Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
NCT03814317Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension
NCT03016468Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH
NCT04246281The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain
NCT00325442FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)
NCT01799473Tyvaso Dosing and Titration Evaluation: TyTRATE Registry
NCT00004497Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
NCT01268553Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
NCT03047369The Myelin Disorders Biorepository Project
NCT07116681Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary Hypertension
NCT00439946Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
NCT00458042Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction
NCT01393795Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients
NCT04827056Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
NCT05943535Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
NCT01795950Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)
NCT00651885Safety Study of UT-15C SR (Oral Treprostinil) in Patients Undergoing a Lower Limb Endovascular Procedure
NCT04870333PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V
NCT05060315Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin
NCT01447407Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine
NCT03332667MIBG With Dinutuximab +/- Vorinostat
NCT01353040Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
NCT01165476Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities
NCT03833323Implantable System for Remodulin Post-Approval Study
NCT00060996Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
NCT01980979Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension
NCT01557660Inhaled Treprostinil for PAH: Open-label Extension
NCT00963027Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil
NCT05231122Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer
NCT00911248PTC299 for Treatment of Neurofibromatosis Type 2
NCT01996254Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System
NCT07923591Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
NCT00494533Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
NCT03497689EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
NCT06814717A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10% Total Body Surface Area Burns
NCT07227103A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial
NCT03626688A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
NCT00067041Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft
NCT05101564Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer
NCT00058929A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension
NCT07612488A Study of CS231295 in Patients With Advanced Solid Tumors
NCT01028651A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
NCT02370095Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
NCT06450041NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
NCT00159250Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
NCT03043651Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF
NCT01353027Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus